Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer

NCT00271505 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Bevacizumab (Avastin)
DRUG: Carboplatin
DRUG: Docetaxel

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]